AffaMed Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 2

  • Investments
  • 3

AffaMed Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to accelerate clinical development of potential new therapies that aim to make a tangible difference in patients' lives. The company specializes in developing and commercializing transformative pharmaceutical products that address critical unmet medical needs in ophthalmology, neurological and psychiatric disorders for patients around the world.

Contact Information

Website
affamed.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • HKRI Centre Two, HKRI Taikoo Hui
  • 288 Shimen Yi Road, Suite 3201-3206
  • Shanghai
  • China
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • HKRI Centre Two, HKRI Taikoo Hui
  • 288 Shimen Yi Road, Suite 3201-3206
  • Shanghai
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AffaMed Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AffaMed Therapeutics‘s full profile, request access.

Request a free trial

AffaMed Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AffaMed Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AffaMed Therapeutics‘s full profile, request access.

Request a free trial

AffaMed Therapeutics Investments (3)

AffaMed Therapeutics’s most recent deal was a Joint Venture with AffaMed Therapeutics & SIFI (Joint Venture) for . The deal was made on 31-Mar-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AffaMed Therapeutics & SIFI (Joint Venture) 31-Mar-2021 Joint Venture Surgical Devices
Graybug Vision 15-Aug-2019 Later Stage VC Drug Delivery
EverInsight Therapeutics 01-Aug-2019 Buyout/LBO Drug Discovery
To view AffaMed Therapeutics’s complete investments history, request access »

AffaMed Therapeutics Exits (1)

AffaMed Therapeutics’s most recent exit was on 15-Aug-2019 from Graybug Vision. The exit was categorized as with 5 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Graybug Vision 15-Aug-2019 Completed
  • 5 buyers
To view AffaMed Therapeutics’s complete exits history, request access »

AffaMed Therapeutics FAQs

  • When was AffaMed Therapeutics founded?

    AffaMed Therapeutics was founded in 2019.

  • Where is AffaMed Therapeutics headquartered?

    AffaMed Therapeutics is headquartered in Shanghai, China.

  • What is the size of AffaMed Therapeutics?

    AffaMed Therapeutics has 40 total employees.

  • What industry is AffaMed Therapeutics in?

    AffaMed Therapeutics’s primary industry is Drug Discovery.

  • Is AffaMed Therapeutics a private or public company?

    AffaMed Therapeutics is a Private company.

  • What is AffaMed Therapeutics’s current revenue?

    The current revenue for AffaMed Therapeutics is .

  • How much funding has AffaMed Therapeutics raised over time?

    AffaMed Therapeutics has raised $170M.

  • Who are AffaMed Therapeutics’s investors?

    Fountainhead Biomedical Holdings, Lake Bleu Capital, Orion (Finland), Partners Investment, and Superstring Capital Management are 5 of 6 investors who have invested in AffaMed Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process